SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-093515
Filing Date
2016-02-03
Accepted
2016-02-03 14:29:14
Documents
3
Period of Report
2016-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-3348_18k.htm 8-K 28564
2 EX-99.1 a16-3348_1ex99d1.htm EX-99.1 17430
3 GRAPHIC g33481mmi001.jpg GRAPHIC 7392
  Complete submission text file 0001104659-16-093515.txt   57596
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 161384372
SIC: 2836 Biological Products, (No Diagnostic Substances)